Elizabeth Cermak Clarus Therapeutics Holdings, Inc. (CRXT) insider trading activity

CRXT Quotes by TradingView

Elizabeth Cermak is Director of Clarus Therapeutics Holdings, Inc.. Currently has a direct ownership of 5,766 shares of CRXT, which is worth approximately $172. The most recent transaction as insider was on Jun 07, 2022, when has been sold 1,922 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5.77K
0% 3M change
0% 12M change
Total Value Held $172

Elizabeth Cermak Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 07 2022
BUY
Grant, award, or other acquisition
-
1,922 Added 25.0%
5,766 Common Stock
Dec 12 2021
BUY
Grant, award, or other acquisition
-
3,844 Added 50.0%
3,844 Common Stock

Also insider at

MBRX
Moleculin Biotech, Inc. Healthcare
Director
EC

Elizabeth Cermak

Director
Houston, TX

Track Institutional and Insider Activities on CRXT

Follow Clarus Therapeutics Holdings, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CRXT shares.

Notify only if

Insider Trading

Get notified when an Clarus Therapeutics Holdings, Inc. insider buys or sells CRXT shares.

Notify only if

News

Receive news related to Clarus Therapeutics Holdings, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CRXT